New supplies of two currently hard-to-find cancer drugs are on the way, according to the FDA. As Dow Jones Newswires reports, the FDA said it would allow the temporary importation of Lipodox, made by Sun Pharma Global FZE and distributed by Caraco Pharmaceutical Laboratories.
New supplies of two currently hard-to-find cancer drugs are on the way, according to the FDA. As Dow Jones Newswires reports, the FDA said it would allow the temporary importation of Lipodox, made by Sun Pharma Global FZE and distributed by Caraco Pharmaceutical Laboratories.
Federal health officials said there will be enough supply of a children’s leukemia drug released in the next couple of weeks to alleviate a shortage.
Roche and Genentech have been informed that a counterfeit product, labeled as Avastin (bevacizumab), has been distributed in the United States. The counterfeit product is not safe or effective and should not be used. Chemical analyses of the counterfeit vials tested to date have confirmed the product does not contain the active ingredients for Avastin.
A crucial medicine to treat childhood leukemia is in such short supply that hospitals across the country may exhaust their stores within the next two weeks, leaving hundreds and perhaps thousands of children at risk of dying from a largely curable disease, federal officials and cancer doctors say.
About two-thirds of women diagnosed with early stage breast cancer want to take part in making decisions about their treatment, according to a new survey of patients from five different countries.
Build lists of practical questions used to guide conversations between you and your doctors and nurses.
Connect with us:
Facebook Twitter YouTube RSSCopyright © 1995-2012 by the National Coalition for Cancer Survivorship
1010 Wayne Avenue, Suite 770 · Silver Spring, MD 20910 · 877-NCCS-YES · info@canceradvocacy.org